Medical Health & Life Science Research News

Global cancer diagnostics market is expected to reach USD 18.4 billion by 2024, at a CAGR of 11.7% in the forecast period 2017 to 2024 available in new report

The report "Global Cancer Diagnostics Market" is expected to reach USD 18.4 billion by 2024 from USD 7.6 billion in 2016, at a CAGR of 11.7% in the forecast period 2017 to 2024.

- Advertising -

Global Cancer Diagnostics Market, By Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melonoma), By Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World) – Trends and Forecast to 2024

Global Cancer Diagnostics Market is expected to reach USD 18.4 billion by 2024 from USD 7.6 billion in 2016, at a CAGR of 11.7% in the forecast period 2017 to 2024.The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Request for Report @ databridgemarketresearch.com/reque…iagnostics-market

Cancer Diagnostics Market – Market Segmentation:

The Cancer Diagnostics Market is segmented on the basis of technology and application.

The Global Cancer Diagnostics Market, by technology, is categorized into two main segments—platform based and instrument-based. Platform-based segment is further segmented into Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Immunohistochemistry (IHC), Next-Generation Sequencing (NGS), DNA Microarrays, Flow Cytometry and other technologies.

- Advertising -

Instrument-based segment is further segmented into Imaging (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), mammography, and ultrasound), and Biopsy.

The global cancer diagnostics market is segmented based on application into lung cancer, breast cancer, colorectal cancer, melanoma and other forms of cancer. Breast cancer diagnosis is expected to hold the largest share of this market in 2015, due to its high prevalence in North America also due to high expense of mammography instruments.

Inquire Report @ databridgemarketresearch.com/inqui…iagnostics-market

Cancer Diagnostics Market – Geographical Segmentation

Based on geography the global cancer diagnostics market  covers data points for 52 countries across multiple geographies namely North & South America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.

North America holds the largest market followed by Asia Pacific which is growing rapidly. Brazil and Middle East are among the others geographies growing prolifically.

North America dominates the market in terms of consumption of hemostats followed by Europe and APAC.

Cancer Diagnostics Market – Competitive Landscape:

Some of the major players operating in this market are Abbott Laboratories, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., Becton, Dickinson and Company, General Electric Company, QIAGEN N.V., Agilent Technologies, Inc., Hoffmann-La Roche Ltd., Siemens Healthcare GmbH, Koninklijke Philips N.V., and C.R. Bard, Inc., Hologic, Inc. among other players.

Table of Content:

  1. INTRODUCTION
  2. MARKET SEGMENTATION
  3. MARKET OVERVIEW
  4. EXECUTIVE SUMMARY
  5. PREMIUM INSIGHTS
  6. GLOBAL CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY

       6.1. OVERVIEW

       6.2. PLATFORM BASED, BY PRODUCT TYPE

       6.3. INSTRUMENT BASED, BY PRODUCT TYPE

  1. GLOBAL CANCER DIAGNOSTICS MARKET, BY APPLICATION
  2. GLOBAL CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY

       9.1. COUNTRYWISE GLOBAL CANCER DIAGNOSTICS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

                9.1.1. NORTH AMERICA

                 9.1.2. EUROPE

                 9.1.3. ASIA-PACIFIC (APAC)

                 9.1.4. LATIN AMERICA

                           9.1.4.1. BRAZIL

                           9.1.4.2. REST OF LATIN AMERICA

                 9.1.5. MIDDLE EAST AND AFRICA

                           9.1.5.1. SOUTH AFRICA

                           9.1.5.2. REST OF MIDDLE EAST AND AFRICA

       9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

  1. GLOBAL CANCER DIAGNOSTICS MARKET: COMPETITIVE LANDSCAPE

       10.1. GLOBAL CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS

       10.2. NORTH AMERICA CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS

       10.3. EUROPE CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS

       10.4. APAC CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS

       10.5. MEA CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS

       10.6. SOUTH AMERICA CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS

       10.7. MERGERS & ACQUISITIONS

       10.8. NEW PRODUCT DEVELOPMENT & APPROVALS

       10.9. EXPANSIONS

       10.10. REGULATORY CHANGES

       10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

  1. GLOBAL CANCER DIAGNOSTICS MARKET, COMPANY PROFILES

       11.1. ABBOTT

                 11.1.1. COMPANY OVERVIEW

                 11.1.2. FINANCIAL ANALYSIS

                 11.1.3. PRODUCT MATRIX

                 11.1.4. RECENT DEVELOPMENTS

                 11.1.5. DATABRIDGE ANALYSIS

       11.2. THERMO FISHER SCIENTIFIC

                 11.2.1. COMPANY OVERVIEW

                 11.2.2. FINANCIAL ANALYSIS

                 11.2.3. PRODUCT MATRIX

                 11.2.4. RECENT DEVELOPMENTS

                 11.2.5. DATABRIDGE ANALYSIS

       11.3. ILLUMINA, INC.

                 11.3.1. COMPANY OVERVIEW

                 11.3.2. FINANCIAL ANALYSIS

                 11.3.3. PRODUCT MATRIX

                 11.3.4. RECENT DEVELOPMENTS

                 11.3.5. DATABRIDGE ANALYSIS

       11.4. GE HEALTHCARE

                 11.4.1. COMPANY OVERVIEW

                 11.4.2. FINANCIAL ANALYSIS

                 11.4.4. PRODUCT MATRIX

                 11.4.4. RECENT DEVELOPMENTS

                 11.4.5. DATABRIDGE ANALYSIS

       11.5. SIEMENS HEALTHCARE GMBH

                 11.5.1. COMPANY OVERVIEW

                 11.5.2. FINANCIAL ANALYSIS

                 11.5.3. PRODUCT MATRIX

                 11.5.4. RECENT DEVELOPMENTS

                 11.5.5. DATABRIDGE ANALYSIS

       11.6. QIAGEN

                 11.6.1. COMPANY OVERVIEW

                 11.6.2. FINANCIAL ANALYSIS

                 11.6.3. PRODUCT MATRIX

                 11.6.4. RECENT DEVELOPMENTS

                 11.6.5. DATABRIDGE ANALYSIS

       11.7. AGILENT TECHNOLOGIES

                 11.7.1. COMPANY OVERVIEW

                 11.7.2. FINANCIAL ANALYSIS

                 11.7.3. PRODUCT MATRIX

                 11.7.4. RECENT DEVELOPMENTS

                 11.7.5. DATABRIDGE ANALYSIS

       11.8. ROCHE DIAGNOSTICS

                 11.8.1. COMPANY OVERVIEW

                 11.8.2. FINANCIAL ANALYSIS

                 11.8.3. PRODUCT MATRIX

                 11.8.4. RECENT DEVELOPMENTS

                11.8.5. DATABRIDGE ANALYSIS

       11.9. KONINKLIJKE PHILIPS N.V.

                 11.9.1. COMPANY OVERVIEW

                 11.9.2. FINANCIAL ANALYSIS

                 11.9.3. PRODUCT MATRIX

                 11.9.4. RECENT DEVELOPMENTS

                 11.9.5. DATABRIDGE ANALYSIS

       11.10. BECTON, DICKINSON & COMPANY

                 11.10.1. COMPANY OVERVIEW

                 11.10.2. FINANCIAL ANALYSIS

                 11.10.3. PRODUCT MATRIX

                 11.10.4. RECENT DEVELOPMENTS

                 11.10.5. DATABRIDGE ANALYSIS

       11.11. C.R. BARD, INC.

                 11.11.1. COMPANY OVERVIEW

                 11.11.2. FINANCIAL ANALYSIS

                 11.11.3. PRODUCT MATRIX

                 11.11.4. RECENT DEVELOPMENTS

                 11.11.5. DATABRIDGE ANALYSIS

       11.12. HOLOGIC, INC.

                 11.12.1. COMPANY OVERVIEW

                 11.12.2. FINANCIAL ANALYSIS

                 11.12.3. PRODUCT MATRIX

                 11.12.4. RECENT DEVELOPMENTS

                 11.12.5. DATABRIDGE ANALYSIS

Browse Full Report Visit @ http://databridgemarketresearch.com/reports/in-vitro-diagnostics/global-cancer-diagnostics-market/

News From

Data Bridge Market ResearchData Bridge Market Research
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...